Highlights
KLSE: DPHARMA (7148)       DUOPHARMA BIOTECH BHD MAIN : Health Care
Last Price Today's Change   Day's Range   Trading Volume
2.83   -0.05 (1.74%)  2.80 - 2.88  687,600
Trade this stock for as low as 0.05% brokerage. Find out more.

Overview

Market Cap: 1,998 Million
NOSH: 706 Million
Avg Volume (4 weeks):1,247,100
4 Weeks Range:2.65 - 2.96
4 Weeks Price Volatility (%):
58.06%
52 Weeks Range:1.44 - 4.38
52 Weeks Price Volatility (%):
47.28%
Average Price Target: 1.88
Price Target Upside/Downside: -0.95
Stamp duty exempted for year 2021

Financial Highlight

Latest Quarter | Ann. Date 31-Dec-2020 [#4]  |  22-Feb-2021
Next QR | Est. Ann. Date: 31-Mar-2021  |  18-May-2021
T4Q P/E | EY: 34.09  |  2.93%
T4Q DY | Payout %: 2.29%  |  78.12%
T4Q NAPS | P/NAPS: 0.91  |  3.11
T4Q NP Margin | ROE: 10.28%  |  9.12%

Headlines

Date Subject
19-Mar-2021 疫情后过渡至新常态 7复苏主题股崛起
23-Feb-2021 Mplus Market Pulse - 23 Feb 2021
28-Jan-2021 [转贴] [Video:浅谈DUOPHARMA BIOTECH BHD, DPHARMA, 7148] - James的股票投资James Share Investing
27-Jan-2021 PublicInvest Research Headlines - 27 Jan 2021
18-Jan-2021 [转贴] 医疗物流领域摩拳擦掌 疫苗概念股走俏
15-Jan-2021 Trading Stocks - Duopharma Biotech
14-Jan-2021 Duopharma next after Pharmaniaga to handle Covid-19 vaccination?
05-Jan-2021 Daily technical highlights – (DPHARMA, DKSH)
21-Dec-2020 ONBOARD THIS STOCK BEFORE IT IS TOO LATE!!!
13-Nov-2020 Mplus Market Pulse - 13 Nov 2020
05-Nov-2020 热门股:联合药业 上挑RM4.23
05-Oct-2020 Trading Stocks - Duopharma Biotech
02-Oct-2020 热门股:联合药业 上挑RM3.80
19-Sep-2020 联合药业上挑RM3.47/敏源
15-Sep-2020 Daily Market Update - 15 Sept 2020 (DPHARMA, PLABS)
13-Sep-2020 [转贴] [Video:浅谈DUOPHARMA BIOTECH BHD, DPHARMA, 7148] - James的股票投资James Share Investing
01-Sep-2020 放眼5年内迈10亿大关‧联合药业跨向区域
01-Sep-2020 (UPDATED WITH MORE DETAILS) NOW SHOWING: The Trilogy of FAST & FURIOUS Shows, PART 6B 6+1
29-Aug-2020 联合药业挑战RM3.89/敏源
25-Aug-2020 热门股:联合药业 上挑RM3.76

Business Background

Duopharma Biotech Berhad, an investment holding company, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia. The company provides products in various forms, including tablets, capsules, syrups, oral antibiotics, creams, hemodialysis solutions, sterile irrigation solutions, sterile powder and small volume injectable forms, dental cartridges, and eye drop preparations. It offers generic and halal pharmaceutical products; and over-the-counter products primarily under the Champs, Flavettes, Proviton, Naturalle, Uphamol, Eye Glo, Donna, and Alucid brands, as well as analgesics, antihistamines, etc. The company also operates under the OMESEC brand name. In addition, it is also involved in the property management activities; and distribution of chemical products. Duopharma Biotech Berhad also exports its products to Vietnam, Ethiopia, Sudan, Southeast Asia, Papua New Guinea, Pakistan, Bangladesh, Sri Lanka, the Republic of Yemen, Singapore, and Hong Kong. The company was formerly known as CCM Duopharma Biotech Berhad and changed its name to Duopharma Biotech Berhad in February 2019. The company was founded in 1979 and is based in Klang, Malaysia. Duopharma Biotech Berhad is a subsidiary of Permodalan Nasional Berhad.
Analyze this stock with MQ Trader system

  11 people like this.
 
bagankia I think everyone is waiting for NPRA approval on Sputnik V .
18/03/2021 12:35 PM
Secret i bought since 4. And Cd 0.2++. Cd already loss almost 40k. This is the most expensive lesson
21/03/2021 3:08 PM
Trevor777 Yes, many were fooled by bicycle man.

Acquisition of vaccines not through Middlemen? What is Solution doing with 3.5 million Cansino? Even when they don't have a plant?
21/03/2021 5:47 PM
Trevor777 What to expect, even PNB dumping.
21/03/2021 5:48 PM
Michael Tan European micronation San Marino begins administering Russia’s Sputnik V vaccine

Philippines to receive 3M doses of Sputnik V vaccine from EUA grant

Indian drugmaker to produce 200 million doses of Russia’s Sputnik V

More and more acceptance over the world... Malaysia soon
22/03/2021 1:05 AM
Trevor777 @Michael, ...and what has that to do with Dpharma currently?

Chinese vaccine SinoVac can be NPRA approved and shooting into arms but Sputnik V is still on drawing board?

And Dpharma is only bottling 6.4 million doses, can this double or triple the price value from original March 2020 at RM1.56?

The prospect to look forward is Gemalaya agrees to co-operate and transfer of technology in a JV with Dpharma for Vaccine manufacturing, creating Malaysia as a production hub. This could possible be in 2022, and not contributing any extraordinary profits in 2021.

Many are stuck at penthouse price and fooled by bicycle man, thinking that only the 2 Pharmaceutical GLCs would greatly benefits and assist Malaysia at the same time.
22/03/2021 6:39 AM
Trevor777 When the price dropped from 3.80 to 3.50, some people alerted the price is going down to 2.00 and we laughed at them....who has the last laugh? Joke is on us to be holding in high valuation. Here we are after -1.00 and at 2.60, hoping for a big break again....second joke.

Leonard is all talk but no action. It would take much more than words to get positive results. Academician are never businessmen. And politicians' words taken with a truck of salt.
22/03/2021 6:40 AM
Keyman188 @Trevor777...Thank you for your support Keyman188 prospective on the counter...

Keyman188 already highlighted so many time since Dec'20 until Jan'21...

Seem like a lot of newbies felt Keyman188 talk cock or "blow water never wipe mouth"...

You all had seen Jan'21 comments ???...

So what is the price range now ???

Is it almost matching with Keyman188 prediction???...

Keyman188 once again to highlight, if upcoming quarterly result unable to growth further, very high possibility anytime shall be neutralised between 1.80 ~ 2.00....

Please spend some time to review past 2 quarterly report...

Keyman188 still casualty to review this company but Keyman188 will not invest 1st either upcoming quarterly result can indicate further growth or until the share price to be neutralised...






Posted by Keyman188 > Jan 1, 2021 9:08 PM | Report Abuse

Keyman188 always like to repeat & repeat to remind market again...

Time to wake up switching to economy recovery stocks...

Smart money already gone & had switched to others....

Keyman188 foresee further downside risk towards 2.80 ~ 3.00......

If unable to support, further downside risk towards 2.55 ~ 2.65...

Don't be hero to fight current level......



Even though you all plan to keep it for long term...

But not at this point since overall this counter sentiment remained very very weak...

Don't burnt your hard earned money......

For more safety margin better be more patience until below 3.00 then decide again......

Fyi, for the past few years record range, 1.30 ~ 1.60.....

Only this year is different because of heading more speculation then shot up above 4.00......

----------------------------------------------------------------------------------------------------------

Posted by Keyman188 > Dec 15, 2020 2:20 PM | Report Abuse

Keyman188 wants to see if the share price drop back to the range 2.00 ~ 2.30 for the next 12 month...then ding dong ding dong this range another 2 /3 years....

wkwkwk...wkwkwk..kekeke...kekeke.....
22/03/2021 7:13 AM
Onghenghuat12 hearsay good news cmg
23/03/2021 12:35 PM
Onghenghuat12 rocket up
23/03/2021 5:14 PM
nokia8250 Hearsay from whom or where?
26/03/2021 11:38 AM
Onghenghuat12 shhhhh
26/03/2021 5:16 PM
Consultant Yeps agree with keyman.. share price value only 1.5-1.7.. play safe
26/03/2021 8:05 PM
Godofgambler Tp8.00 coming
27/03/2021 6:53 AM
bigby7 Kena vaccine.. Mak aku hijau..
Tangan sakit giler babi
27/03/2021 8:42 PM
eYuppie GodofGambler, why you said TP 8.00 coming? Cakap syok syok kah?
29/03/2021 3:24 PM
Consultant talk big haha godofgambler
30/03/2021 4:22 PM
Aurora13 Back to normal price... Anyway it shldnt have had gone up at the first place... Lol
30/03/2021 10:28 PM
eYuppie When EPF buy, PNB sell and when EPF sell, PNB buy. Why like this??!
31/03/2021 5:47 PM
Onghenghuat12 they sell when they earn. whats wrong
01/04/2021 12:19 AM
Trevor777 This is what's wrong........the U-turn gets bigger.....so who needs GLCs Pharmaceuticals anymore?

https://www.msn.com/en-my/news/national/hasten-approval-of-new-vaccines-putrajaya-told/ar-BB1f8Eoe?li=BBr8Mk9
01/04/2021 8:34 AM
fundamentalist6632 Back to RM3 soon.
02/04/2021 3:53 PM
AbsoluteNoob Russian vaccine coming via them?
02/04/2021 4:37 PM
Godofgambler TP 8.00 coming!!!!!
02/04/2021 5:33 PM
zedgehong TP 4 is enough already
02/04/2021 7:07 PM
cat1815 zedgehong, ya... stuck for long long time
02/04/2021 7:11 PM
cat1815 Godofgambler, any good news?
02/04/2021 7:11 PM
Michael Tan Russia’s Sputnik V formula could be updated to protect against new coronavirus variants in just two days using new gene technology
www.google.com/amp/s/www.rt.com/russia/519926-sputnik-formula-update-gene-technology/amp/
02/04/2021 9:07 PM
Godofgambler Wow great news.... Tp8.00 on the way
04/04/2021 6:21 PM
maney Vaccination is free for Msians / foreigners here even if go private hospitals/ clinics/ pharma. All paid by gov. Profit margin won’t be great.
04/04/2021 6:44 PM
nokia8250 Come on la, realistic la a bit. TP8 coming. Please. Sounds like a child making comment.
05/04/2021 1:14 PM
btuscy @godofgambler, as ur name suggested, u think this playing roulette? TP8? lol
05/04/2021 1:47 PM
wjc4195 tp 10.5 coming
07/04/2021 4:09 AM
emc2garylow Dividen 6 cents, ex date 21 April
08/04/2021 10:59 PM
yjasonng2020 https://twitter.com/JJ39132147/status/1380331792058642434?s=19
09/04/2021 9:30 AM
sciwalker Delayed the agreement again
09/04/2021 5:56 PM
DrLimKH that's why...UCrest is pleased to announce that the Company has on 9 April 2021, entered into a MOU with RDIF for management of manufacturing of Sputnik V
09/04/2021 7:39 PM
DrLimKH true circus
09/04/2021 7:39 PM
fengpinglangjin ucrest manage production sell to rdif..rdif sell to duopharma...ucrest n rdif will earn the big money...
10/04/2021 7:22 AM
fengpinglangjin Ucrest find manufacturer ...rfid wil transfer tech....so basically ucrest appoint who who will be manufacturer....
10/04/2021 9:42 AM
Trevor777 IT Software company can be pharmaceutical supplier...WOW! Malaysia Bolih. No wonder the Vaccine registration is lacking far behind. You'll never know what is shot into your arms next.

Look at Solution, Kanger and Bintai...goreng with MOU, LOI... plant also don't have. How to manufacture? How long to set up? How about the costs? And the gestation period to completion?

No wonder Bursa is for easy come, easy go money. And with a bought Oxford degree...apa pun bolih, u-turn easy on bicycle.
10/04/2021 10:42 AM
Trevor777 This is also partly to put blame on RFID, for they see money more than their partners. Green color of money is better looking that the multi-colored suits and red noses on their partners.
10/04/2021 10:46 AM
Knm_bottomed This stock will collapse in 2-3 months
11/04/2021 8:18 AM
HonLee Very funny
11/04/2021 1:25 PM
Michael Tan Covid-19: India approves Russian vaccine Sputnik V for emergency use
13/04/2021 6:16 AM
Trevor777 Wonder what's the meaning of 885,300 done at 2.88 (day's top buying volume) and at last 9 minutes before closing?
14/04/2021 5:06 PM
feezzy89 will this counter go further than rm4?
15/04/2021 2:30 PM
Michael Tan RDIF, GL RAPHA AND ISU ABXIS TO COOPERATE FOR PRODUCTION OF SPUTNIK V IN KOREA
16/04/2021 1:38 AM
nicholas99 what the . dpharma is doing?

Sputnik inks deal with UCREST to mass produce.. sputnik V..
16/04/2021 12:23 PM
nicholas99 Dpharma directors so incompetant. do nothing. sit on their throne..
16/04/2021 12:25 PM


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Stock Screener using Technical and Fundamental criteria
MQ Affiliate
Join the MQ Affiliate Program today to earn rewards
 
 

520  401  580 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 UCREST 0.35+0.055 
 FOCUS 0.15-0.09 
 MINDA 0.155-0.005 
 LKL 0.315-0.025 
 KEYASIC 0.15+0.01 
 RUBEREX 1.47+0.10 
 CAREPLS 2.08+0.16 
 FOCUS-PA 0.015-0.005 
 BJCORP 0.38-0.015 
 HSI-HGK 0.175-0.02 

FEATURED POSTS

1. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!
PARTNERS & BROKERS